Dubovsky Filip has filed 28 insider transactions across 1 company since June 2023.
Most recent transaction: a option exercise of 1404 shares of NOVAVAX INC ($NVAX) on June 17, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 1404 | $6.97 | 68,017.0000 | 100,768,000 | 2.11% | 0.00% |
| June 17, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 12500 | $6.09 | 80,517.0000 | 100,768,000 | 18.38% | 0.01% |
| June 17, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | S | Common Stock | 12500 | $14.46 | 68,017.0000 | 100,768,000 | 15.52% | 0.01% |
| June 17, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | S | Common Stock | 1404 | $14.54 | 66,613.0000 | 100,768,000 | 2.06% | 0.00% |
| June 17, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Stock Option (Right to Buy) | 1404 | $6.97 | 46,324.0000 | 100,768,000 | 2.94% | 0.00% |
| June 17, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Stock Option (Right to Buy) | 12500 | $6.09 | 37,500.0000 | 100,768,000 | 25.00% | 0.01% |
| May 14, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 19652 | $6.97 | 86,265.0000 | 100,768,000 | 29.50% | 0.02% |
| May 14, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | S | Common Stock | 47312 | $13.90 | 38,953.0000 | 100,768,000 | 54.84% | 0.05% |
| May 14, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Stock Option (Right to Buy) | 19652 | $0.00 | 47,728.0000 | 100,768,000 | 29.17% | 0.02% |
| March 1, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | A | Restricted Stock Units | 144000 | $0.00 | 144,000.0000 | 100,768,000 | 9999.99% | 0.14% |
| March 10, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 5376 | $0.00 | 69,210.0000 | 100,768,000 | 8.42% | 0.01% |
| March 10, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | F | Common Stock | 2597 | $5.45 | 66,613.0000 | 100,768,000 | 3.75% | 0.00% |
| March 10, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Restricted Stock Units | 5376 | $0.00 | 5,376.0000 | 100,768,000 | 50.00% | 0.01% |
| March 7, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 19444 | $0.00 | 73,226.0000 | 100,768,000 | 36.15% | 0.02% |
| March 7, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | F | Common Stock | 9392 | $5.61 | 63,834.0000 | 100,768,000 | 12.83% | 0.01% |
| March 7, 2024 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Restricted Stock Units | 19444 | $0.00 | 0.0000 | 100,768,000 | 100.00% | 0.02% |
| Dec. 14, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 2833 | $5.69 | 55,150.0000 | 78,183,000 | 5.42% | 0.00% |
| Dec. 14, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | F | Common Stock | 1368 | $5.69 | 53,782.0000 | 78,183,000 | 2.48% | 0.00% |
| Dec. 14, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Restricted Stock Units | 2833 | $0.00 | 0.0000 | 78,183,000 | 100.00% | 0.00% |
| Nov. 5, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 1400 | $7.06 | 52,994.0000 | 78,183,000 | 2.71% | 0.00% |
| Nov. 5, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | F | Common Stock | 677 | $7.06 | 52,317.0000 | 78,183,000 | 1.28% | 0.00% |
| Nov. 5, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Restricted Stock Units | 1400 | $0.00 | 0.0000 | 78,183,000 | 100.00% | 0.00% |
| Sept. 16, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 12644 | $7.71 | 57,702.0000 | 78,183,000 | 28.06% | 0.02% |
| Sept. 16, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | F | Common Stock | 6108 | $7.71 | 51,594.0000 | 78,183,000 | 10.59% | 0.01% |
| Sept. 16, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Restricted Stock Units | 12644 | $0.00 | 0.0000 | 78,183,000 | 100.00% | 0.02% |
| June 16, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Common Stock | 4155 | $8.04 | 47,065.0000 | 78,183,000 | 9.68% | 0.01% |
| June 16, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | F | Common Stock | 2007 | $8.04 | 45,058.0000 | 78,183,000 | 4.26% | 0.00% |
| June 16, 2023 | NOVAVAX INC | $NVAX | Dubovsky Filip | President, R&D | M | Restricted Stock Units | 4155 | $0.00 | 0.0000 | 78,183,000 | 100.00% | 0.01% |